A detailed history of Bdo Wealth Advisors, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bdo Wealth Advisors, LLC holds 300 shares of AXSM stock, worth $27,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$27,219
Previous $18,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$39.94 - $79.72 $27,958 - $55,804
-700 Reduced 70.0%
300 $0
Q3 2022

Nov 02, 2022

SELL
$36.06 - $69.85 $36,060 - $69,850
-1,000 Reduced 50.0%
1,000 $45,000
Q2 2022

Aug 25, 2022

SELL
$21.74 - $46.75 $10,870 - $23,375
-500 Reduced 20.0%
2,000 $77,000
Q1 2020

May 15, 2020

BUY
$41.2 - $101.31 $103,000 - $253,275
2,500 New
2,500 $147,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Bdo Wealth Advisors, LLC Portfolio

Follow Bdo Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdo Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bdo Wealth Advisors, LLC with notifications on news.